Primary study · included by 1 review

225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings.

Sathekge 2023 · Sathekge Mike, Bruchertseifer Frank, Vorster Mariza, et al. · European journal of nuclear medicine and molecular imaging · 2023

Included by

Non-Cochrane · intervention · 2026 · cited as Sathekge 2023 · Reference list refs 21-53; Table 2; Supplementary Table 5

The review does not say which of its outcomes this study informs.

1 including review in total.